Human populations and natural ecosystems are bound to be exposed to ionizing radiation1from the deposition of artificial radionuclides resulting from nuclear accidents, nuclear devices2or radiological dispersive devices ("dirty bombs"). On the other hand, NORM industries such as3phosphate production or uranium mining, contribute to the on site storage of residuals with enhanced4concentrations of natural radionuclides. Therefore, in the context of the European agreements5concerning nuclear energy, namely the EURATOM (European Atomic Energy Community) Treaty,6monitoring is an essential feature of the environmental radiological surveillance. In this work, we7obtain 3D maps from outdoor scenarios, and complete such maps with measured radiation levels8and with its radionuclide signature. In such scenarios, we face challenges such as unknown and9rough terrain, limited number of sampled locations and the need for different sensors and therefore10different tasks. We propose a radiological solution for scouting, monitoring and inspecting an area of11interest, using a fleet of drones and a controlling ground station. First, we scout an area with a LiDAR12onboard a drone to accurately 3D-map the area. Then, we monitor that area with a Geiger-Muller13sensor at a low-vertical distance from the ground to produce a radiological (heat)map that is overlaid14on the 3D map of the scenario. Next, we identify the hotspots of radiation, and inspect them in detail15using a drone by landing on them, to reveal its radionuclide signature using a CZT sensor. We present16the algorithms used to implement such tasks both at the ground station and on the drones. The three17mission phases were validated using actual experiments in three different outdoor scenarios. We18conclude that drones can not only perform the mission efficiently, but in general they are faster and19as reliable as personnel on the ground

Background and objectives: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ME/CFS is a common complex multi-system disease with a significant impact on the quality of life of patients and their families, yet the majority of ME/CFS patients go unrecognised or undiagnosed. For two decades the medical education establishment in the UK has been challenged to remedy these failings, but little has changed. This study was designed to ascertain the current UK medical school education on ME/CFS and to identify challenges and opportunities to inform the future of medical education. Materials and methods: A questionnaire, developed under the guidance of the Medical Schools Council, was sent to all 34 UK Medical Schools to collect data for the academic year 2018-2019. Results: Responses were provided by 22 out of a total of 34 medical schools (65%). 59% of respondents taught ME/CFS, led by specialists drawn from 6 medical disciplines. Teaching delivery was usually by lecture; however, discussion case studies and e-learning were used. 7 schools included questions on ME/CFS in their examinations and 3 schools reported likely clinical exposure to ME/CFS patients. 64% of respondents were interested in receiving further teaching aids in ME/CFS. None of the schools shared details of their teaching syllabus so it was not possible to ascertain what students were being taught. Conclusions: UK medical school teaching in ME/CFS is shown to be inadequate. Several medical disciplines, with known differences about the disease, need to set these aside to give greater clarity in teaching undergraduates so they can more easily recognise and diagnose ME/CFS. Improvements are proposed in ME/CFS medical education consistent with the international paradigm shift in biomedical understanding of this disease. Many medical schools (64% of respondents) acknowledge this need by expressing a strong appetite for the development of further teaching aids and materials. The GMC and MSC are called upon to use their considerable influence to bring about the appropriate changes to medical school curricula so future doctors can recognise, diagnose and treat ME/CFS. The GMC should also consider creating a registered speciality encompassing ME/CFS, post viral fatigue and Long Covid.